Sequenom, Inc. (SQNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sequenom, Inc. (SQNM)

SQNM 2.390

0.0%

Sep 8 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (192)	5/4/2006 8:06:07 PM
From: Teddy	Read Replies (1) of 364

Nice increase in revenue while decreasing cost. Still a long way to go, but 'directionly correct,' Sequenom's revenues for the first quarter were $6.9 million, or a 61% increase compared to $4.3 million for the first quarter of 2005. Total costs and expenses for the quarter were $11.0 million, compared to $12.2 million for the first quarter of 2005. Total costs and expenses for the quarters ended March 31, 2006 and 2005 include $0.2 million and $0.1 million, respectively, of share-based compensation expenses. The net loss for the first quarter was $3.7 million, or $0.09 per share, compared to $7.4 million, or $0.19 per share for the first quarter of 2005.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next